Suppliers and packagers for generic pharmaceutical drug: GEPIRONE HYDROCHLORIDE

GEPIRONE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Fabre Kramer	EXXUA	gepirone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021164	NDA	Aytu Therapeutics, LLC	23594-150-30	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (23594-150-30)	2025-10-01
Fabre Kramer	EXXUA	gepirone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021164	NDA	Aytu Therapeutics, LLC	23594-150-32	32 TABLET, EXTENDED RELEASE in 1 BOTTLE (23594-150-32)	2025-10-01
Fabre Kramer	EXXUA	gepirone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021164	NDA	Aytu Therapeutics, LLC	23594-151-30	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (23594-151-30)	2025-10-01
Fabre Kramer	EXXUA	gepirone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021164	NDA	Aytu Therapeutics, LLC	23594-152-30	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (23594-152-30)	2025-10-01

GEPIRONE HYDROCHLORIDE Suppliers (API and Finished Dosage) and Who Makes It Today

Last updated: May 29, 2026

Executive summary: Gepirone hydrochloride is supplied through a narrow set of specialty/API manufacturers and custom synthesis houses rather than a broad, multi-US supplier base seen with larger generic APIs. The supply chain typically bifurcates into (1) API sourcing from contract manufacturers and (2) custom manufacture of finished dosage forms for research, clinical trials, and limited commercial needs. Publicly searchable supplier coverage is uneven because gepirone is a niche, development-stage-to-rare-use product, and many suppliers list only via distributors or NDA-based catalogs.

Who supplies gepirone hydrochloride API (active pharmaceutical ingredient) and what supplier types exist?

Featured answer: Gepirone hydrochloride API is generally sourced from (a) contract API manufacturers that do small-volume custom synthesis and (b) specialized chemical distributors that route orders from in-house or partnered production.

API supply model for niche CNS/psychiatric intermediates

Common supplier categories for gepirone hydrochloride:

• Custom synthesis / toll API manufacturers: Produce gepirone hydrochloride from defined synthetic routes for clinical/early commercial supply. These suppliers typically do batch documentation, impurity profiling, and regulatory file packages under QMS.
• API distribution networks: Independent distributors sell branded or labeled API lots procured from one or two underlying manufacturers. They often provide CoA, typical spec sheets, and lead times but do not name the originating site.
• Integrated specialty chemical manufacturers: Companies that make amine hydrochlorides and related intermediates and can scale to API under a development program.

What to expect in supplier documentation

For gepirone hydrochloride procurement, supplier dossiers in practice tend to include:

• CoA and specification sheet for identity, assay, water content/LOD, and key impurities
• Manufacturing site and batch record summary (often redacted by distributors)
• Regulatory packaging: DMF/CEP references only when available for the specific supplier lot lineage

What are the strongest supplier channels for gepirone hydrochloride (direct manufacturers vs distributors)?

Featured answer: For gepirone hydrochloride, the most reliable channel is often direct contracting with a specialty API manufacturer, with distributors as a secondary route when lead-time or minimum order quantities are misaligned.

Direct-to-manufacturer channel advantages

• Access to API intermediate chain-of-custody
• Better visibility into impurity profiles and process consistency
• Easier alignment to clinical batch requirements (stability, scale, and analytical methods)

Distributor channel advantages

• Shorter procurement cycle for screening and small batch
• Fewer contracting steps when used for non-IND or early feasibility

Procurement-risk points

• API lot-to-lot variability risk is higher through distributors unless the distributor guarantees the same underlying production history.
• If a supplier has multiple synthesis routes, the impurity fingerprint can shift, affecting analytical method validation.

Which finished-dose suppliers make gepirone hydrochloride tablets or alternative dosage forms?

Featured answer: Finished-dose suppliers for gepirone hydrochloride are typically limited and depend on whether a specific market is active. Supply is more commonly encountered as clinical trial material than as broadly stocked commercial product.

Dosage-form sourcing patterns

• Clinical trial supply: Manufactured under contract by dose-form CDMOs using the selected API specification.
• Niche commercial supply: Often handled by the sponsor’s manufacturing partner rather than multiple interchangeable finished-dose companies.

Common dosage-form manufacturing constraints

Finished-dose manufacture of niche APIs can be constrained by:

• specialized tablet compaction parameters tied to API physicochemical properties
• trace impurity controls that require aligned API and formulation specs

Does gepirone hydrochloride have multiple pharmacopeial grades suppliers, or is it specialty only?

Featured answer: Gepirone hydrochloride is generally treated as a specialty API rather than a commodity pharmacopeial-grade chemical. As a result, suppliers may offer limited-grade offerings tied to clinical readiness.

Typical grade structure seen in supplier listings

• Research-grade (for screening): higher variability, limited documentation
• Process development/clinical grade: defined impurity limits, stability program
• Commercial-grade: available only if there is an ongoing licensed product run

What supplier qualification is required for gepirone hydrochloride in FDA/clinical settings?

Featured answer: Supplier qualification for gepirone hydrochloride in regulated settings typically requires cGMP manufacture (or a clear audit trail), method-aligned CoAs, and batch reproducibility.

Typical qualification artifacts

• cGMP compliance statements for the specific manufacturing site and activity
• CoA with validated analytical methods (or bridged methods)
• Stability data for the proposed retest and shelf-life periods
• Change control and deviation history at the API manufacturing level

What buyers usually insist on for niche APIs

• impurity panel alignment to the intended regulatory package
• documentation of chloride salt formation controls if relevant to the supplier route
• controls on residual solvents and heavy metals

What are the key supplier selection criteria for gepirone hydrochloride?

Featured answer: Buyers select gepirone hydrochloride suppliers on (1) regulatory readiness, (2) impurity control capability, (3) lead time and MOQ, and (4) analytical method fit to their quality system.

Selection checklist

• Regulatory readiness: cGMP, documentation maturity, and whether DMF/CEP-like materials exist for the supplier lot
• Analytical support: CoA consistency, validated methods, ability to support method transfer
• Process control: stable impurity profile across batches
• Supply reliability: lead time, batch scheduling capacity, and change control discipline
• Quality system: audit outcomes, CAPA history, and documentation traceability

Key supplier and sourcing reality for gepirone hydrochloride (commercial implications)

Featured answer: The supplier landscape for gepirone hydrochloride is thin enough that buyers should treat sourcing as a project, not a commodity purchase, because lot specification alignment and impurity profile consistency drive downstream formulation and regulatory timelines.

Commercial and R&D consequences

• API sourcing delays can shift trial timelines due to analytical method validation and stability pull schedules.
• Partnering with one API source for the duration of a program can reduce risk versus switching suppliers mid-development.

Key Takeaways

• Gepirone hydrochloride is supplied through specialty API manufacturing and distributor channels, not a broad commodity market.
• Finished-dose supply is typically limited and most visible as clinical trial material.
• Supplier selection hinges on impurity control, cGMP documentation, and analytical method alignment.
• Because the market is niche, buyers should expect lead-time and specification-continuity risk unless they lock to a qualified direct manufacturer.

FAQs

1. How do I find gepirone hydrochloride suppliers for clinical trial material?
   Use cGMP-specialty API CDMOs and request supply capability for your intended batch size, impurity limits, and analytical method compatibility.

2. Is gepirone hydrochloride available through large API distributors?
   Often via distributors, but origin-site transparency can be limited; direct qualification of the underlying manufacturer is usually needed for regulated programs.

3. What impurity controls matter most for gepirone hydrochloride sourcing?
   The supplier’s impurity fingerprint and its stability across batches, including salt-formation consistency and residual solvent/heavy-metal controls.

4. Can supplier switching delay formulation development for gepirone hydrochloride?
   Yes. Switching can change physicochemical attributes and impurity profiles, forcing method bridging and stability rework.

5. What documentation should gepirone hydrochloride API suppliers provide?
   CoA with validated specs, manufacturing site details, batch traceability, and quality documentation aligned to your regulatory stage.

References

1. (No sources cited: no publicly verifiable supplier list for gepirone hydrochloride was provided in the prompt and no supplier identifications can be asserted without cited evidence.)